Inactive Instrument

A1M Pharma AB Stock Nasdaq Stockholm

Biotechnology & Medical Research

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

06-12	Guard Therapeutics Initiates Divestment of GTX Platform	MT
06-11	Guard Therapeutics to Acquire Disruptive Pharma in Reverse Takeover	MT

Last Transcript: A1M Pharma AB

Guard Therapeutics International AB - Special Call

25-10-31

More transcripts

Analysts' recommendations: A1M Pharma AB

25-10-26	Guard Therapeutics Announces Top-Line Results from Phase 2b POINTER Study	CI
25-09-11	Redeye Initiates Coverage of Guard Therapeutics with Target Value of SEK 43	FW

More recommendations

News in other languages: A1M Pharma AB

21-04-07	ERS Test AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG
21-04-07	ERS Test AG: Vorabbekanntmachung über die Veröffentlichung von Zahlungsberichten gemäß § 116 WpHG

More news

Managers and Directors: A1M Pharma AB

Manager	Title	Age	Since
Tobias Larsson Agervald CEO	Chief Executive Officer	50	2019-01-14
Karin Botha DFI	Director of Finance/CFO	53	2020-09-13
Michael Reusch CTO	Chief Tech/Sci/R&D Officer	66	2021-12-31

Director	Title	Age	Since
Göran Forsberg BRD	Director/Board Member	63	2019-05-28
Johannes Hulthe BRD	Director/Board Member	56	2019-05-28
Johan Bygge CHM	Chairman	70	2021-04-30

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+2.09%	+5.19%	-1.45%	+4.99%	47.18B
REVOLUTION MEDICINES, INC.	-2.77%	+10.48%	+409.05%	+600.11%	39.82B
IQVIA HOLDINGS INC.	-0.03%	+12.81%	+22.61%	-14.04%	32.25B
BEONE MEDICINES AG	-1.73%	+3.20%	+17.72%	+59.83%	31.68B
CELLTRION, INC.	-3.29%	+7.98%	+14.01%	+29.96%	24.59B
ASCENDIS PHARMA A/S	+1.15%	+11.79%	-	-	16.57B
MEDPACE HOLDINGS, INC.	-0.96%	+11.85%	+68.73%	+120.51%	15.12B
EUROFINS SCIENTIFIC SE	-0.50%	+1.79%	+12.24%	+17.14%	13.69B
IONIS PHARMACEUTICALS, INC.	-1.74%	+4.34%	+100.68%	+93.25%	13.1B
Average	-0.86%	+7.32%	+80.45%	+113.97%	26B
Weighted average by Cap.	-0.74%	+7.36%	+93.73%	+136.08%

See all sector performances

Guard Therapeutics International AB (publ), formerly A1M Pharma AB, is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based on the alpha-1-microglobulin (A1M) protein. The protein serves as a radical inhibitor, an antioxidant, a protector against free hemoglobin and a tissue repairer. A1M is a candidate for different therapeutic and diagnostic uses, such as alleviation of autoimmune diseases and stroke treatment. The Company works with the protein and conducts research at the Biomedical Center in Lund University, Sweden. The Company develops a drug for intravenous treatment of preeclampsia, a condition that can occur during pregnancy and can contribute to premature deliveries.

Employees

Sector

Biotechnology & Medical Research

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	32.27M 3.33M 2.91M 2.69M 2.51M 4.73M 315M 4.81M 12.53M 155M 12.51M 12.23M 541M	P/E 2026 *	0.7x	P/E 2027 *	0.62x
Enterprise Value	-83.73M -8.64M -7.56M -6.98M -6.51M -12.27M -817M -12.49M -32.51M -403M -32.46M -31.73M -1.4B	EV / Sales 2026 *	-0.68x	EV / Sales 2027 *	-1.14x
Free-Float	65.85%	Yield 2026 *	-	Yield 2027 *	-

06-12	Guard Therapeutics Initiates Divestment of GTX Platform	MT
06-11	Guard Therapeutics to Acquire Disruptive Pharma in Reverse Takeover	MT
06-11	Guard Therapeutics announces reverse takeover and planned name change	FW
06-09	Disruptive Pharma Holding Ab entered into a conditional agreement to acquire Guard Therapeutics International AB (OM:GUARD) in a reverse merger transaction in a transaction valued at SEK 61 million.	CI
05-11	Guard Therapeutics loss before and after tax SEK 6.4 mln	RE
05-11	Guard Therapeutics International AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-13	Seven stocks hit new 52-week lows on the Stockholm Stock Exchange so far today	FW
04-10	Three stocks hit new 52-week lows on the Stockholm Stock Exchange so far today	FW
03-31	Guard Therapeutics updates on strategic review	RE
03-31	Guard Therapeutics nears next phase of strategic review	FW
03-30	Guard Therapeutics International AB Provides Update on Strategic Review and Considers Multiple Strategic Alternatives	CI
02-20	Guard Therapeutics International net sales SEK 0 thousand	RE
02-20	Guard Therapeutics International AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

06-12	Guard Therapeutics Initiates Transaction Process for the GTX Platform	AQ
06-10	Guard Therapeutics has entered into a conditional agreement for a reverse takeover with Disruptive Pharma	AQ
04-09	Guard Therapeutics provides information regarding observation status on Nasdaq First North Growth Market	AQ
03-31	Guard Therapeutics provides update on strategic review	AQ
02-05	Guard Therapeutics Announces Changes to the Company’s Management Team	AQ

	2026 *	2027 *
Net sales	123M 12.69M 11.11M 10.25M 9.57M 18.02M 1.2B 18.34M 47.75M 592M 47.68M 46.61M 2.06B	123M 12.69M 11.11M 10.25M 9.57M 18.02M 1.2B 18.34M 47.75M 592M 47.68M 46.61M 2.06B
Net income	51M 5.26M 4.61M 4.25M 3.97M 7.47M 498M 7.61M 19.8M 246M 19.77M 19.33M 855M	58M 5.98M 5.24M 4.84M 4.51M 8.5M 566M 8.65M 22.52M 279M 22.48M 21.98M 973M
Net Debt	-116M -11.97M -10.48M -9.67M -9.02M -17M -1.13B -17.3M -45.03M -558M -44.97M -43.96M -1.95B	-172M -17.75M -15.53M -14.34M -13.38M -25.2M -1.68B -25.65M -66.77M -828M -66.67M -65.18M -2.88B

A1M Pharma AB Stock Nasdaq Stockholm

Stocks

Biotechnology & Medical Research

Valuation: A1M Pharma AB

Latest news : A1M Pharma AB

Last Transcript: A1M Pharma AB

Analysts' recommendations: A1M Pharma AB

Press Releases: A1M Pharma AB

News in other languages: A1M Pharma AB

Managers and Directors: A1M Pharma AB

Other Biotechnology & Medical Research

Financials

Company Profile